PATENT CLAIM ANALYSIS

Application Number: 15913233
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["435", "006000"]

Abstract:
The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of an Adiponectin (ADIPOQ), in particular, by targeting natural antisense polynucleotides of an Adiponectin (ADIPOQ). The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of Adiponectins (ADIPOQ)s.

Claim (Index 1):
A method of upregulating a function of and/or the expression of an Adiponectin (ADIPOR2) polynucleotide in patient cells or tissues in vivo or in vitro comprising: contacting said cells or tissues with at least one antisense oligonucleotide 10 to 30 nucleotides in length wherein said at least one oligonucleotide has at least 90% sequence identity to a reverse complement of a polynucleotide comprising 10 to 30 consecutive nucleotides within nucleotides 1 to 875 of SEQ ID NO: 5, or nucleotides 1 to 194 of SEQ ID NO: 6; thereby upregulating a function of and/or the expression of the Adiponectin (ADIPOR2) polynucleotide in patient cells or tissues in vivo or in vitro.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 90.0
- Lexical Diversity: 1.65
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13388782', '15050577', '14696392', '13695801', '14701998']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.785630046943136
- 35 USC 102 Novelty (BERT): 0.6702794697902165
- Combined Prediction Score: 0.7740949892278441
- Mean Citation Score: 693.699324
- Max Citation Score: 755.0941
- Similarity Product: 641.7728889731468

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test